Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
…, O Brandau, T Oohashi, GR Howell, JM Bye, AP Cahn… - Nature …, 1998 - nature.com
X-linked lymphoproliferative syndrome (XLP or Duncan disease) is characterized by extreme
sensitivity to Epstein-Barr virus (EBV), resulting in a complex phenotype manifested by …
sensitivity to Epstein-Barr virus (EBV), resulting in a complex phenotype manifested by …
[HTML][HTML] EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated
in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which …
in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which …
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
L Shulgina, AP Cahn, ER Chilvers, H Parfrey, AB Clark… - Thorax, 2013 - thorax.bmj.com
Background Idiopathic pulmonary fibrosis (IPF) is a fatal condition with limited treatment options.
However, in a previous small study, co-trimoxazole was found to be beneficial. Methods …
However, in a previous small study, co-trimoxazole was found to be beneficial. Methods …
Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
D Singh, J Brooks, G Hagan, A Cahn, BJ O'Connor - Thorax, 2008 - thorax.bmj.com
Background: The combination of salmeterol and fluticasone propionate (SFC) and tiotropium
bromide (TIO) are commonly used treatments in chronic obstructive pulmonary disease (…
bromide (TIO) are commonly used treatments in chronic obstructive pulmonary disease (…
Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial
EH De Boever, C Ashman, AP Cahn… - Journal of Allergy and …, 2014 - Elsevier
Background Approximately 5% to 10% of asthmatic patients achieve incomplete symptom
control on current therapies. The association of IL-13 with asthma pathology and reduced …
control on current therapies. The association of IL-13 with asthma pathology and reduced …
[HTML][HTML] Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
B Forbes, R O'Lone, PP Allen, A Cahn, C Clarke… - Advanced drug delivery …, 2014 - Elsevier
Alveolar macrophage (AM) responses are commonly induced in inhalation toxicology studies,
typically being observed as an increase in number or a vacuolated ‘foamy’ morphology. …
typically being observed as an increase in number or a vacuolated ‘foamy’ morphology. …
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler
D Prime, W De Backer, M Hamilton, A Cahn… - Journal of aerosol …, 2015 - liebertpub.com
Background: Two studies were undertaken to characterize the maximal effort inhalation
profiles of healthy subjects and patients with asthma or chronic obstructive pulmonary disease (…
profiles of healthy subjects and patients with asthma or chronic obstructive pulmonary disease (…
[HTML][HTML] A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
…, XB Ruiz, H Boughanmi, A Cahn… - European …, 2023 - Eur Respiratory Soc
Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) and dysregulated
myeloid cell responses are implicated in the pathophysiology and severity of COVID-19. …
myeloid cell responses are implicated in the pathophysiology and severity of COVID-19. …
A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR)
J Patel, A Beishuizen, XB Ruiz, H Boughanmi, A Cahn… - medRxiv, 2021 - medrxiv.org
BACKGROUND Increasing age is a risk factor for COVID-19 severity and mortality;
emerging science implicates GM-CSF and dysregulated myeloid cell responses in the …
emerging science implicates GM-CSF and dysregulated myeloid cell responses in the …
Homozygous deletions at 3p12 in breast and lung cancer
…, J Xiong, C Grundy, I Roberts, L James, A Cahn… - Oncogene, 1998 - nature.com
We have constructed a physical map of the region homozygously deleted in the U2020 cell
line at 3p12, including the location of putative CpG islands. Adjacent to one of these islands, …
line at 3p12, including the location of putative CpG islands. Adjacent to one of these islands, …